GABRIEL SMITH: Open Payments
NPI 1396206470 · PRESTONSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 28 payments from 9 companies in 2025. Trend: 2023 $731 · 2024 $707 · 2025 $567
Food & beverage: $547Education: $20
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $193 |
| UCB, Inc. | 4 | $72 |
| SHIELD THERAPEUTICS INC | 1 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| Novartis Pharmaceuticals Corporation | 4 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| ABBVIE INC. | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $16 |
Products named: Kerendia, Bimzelx, ACCRUFER, CAPLYTA, LEQVIO, TRINTELLIX, UBRELVY, VOYXACT.
Industry payments across KY — which companies pay providers there.
